News - Copaxone

Filter

Current filters:

Copaxone

Popular Filters

MS therapeutics market led by Copaxone

17-09-2013

The multiple sclerosis (MS) therapeutics market has been forecast to increase at a compound annual growth…

CopaxoneMarkets & MarketingNeurologicalPharmaceuticalTeva Pharmaceutical Industries

Teva Pharma sees slowdown in generic revenues

01-08-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world largest generics firm but with a…

CopaxoneFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Court ruling favors Mylan in Copaxone patent dispute

17-07-2013

A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Teva fleshes out restructuring plan; licenses Xenon pain drug for $376 million

12-12-2012

Teva Pharmaceutical Industries (NYSE: TEVA's new chief executive Jeremy Levin has outlined the company's…

CopaxoneFinancialGenericsLicensingPatentsPharmaceuticalResearchTeva Pharmaceutical IndustriesXenon Pharmaceuticals

Teva gets favorable UK Copaxone patent ruling

12-07-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the UK High Court of Justice issued…

CopaxoneEuropeGenericsLegalMylan LaboratoriesNeurologicalPatentsPharmaceuticalTeva Pharmaceutical Industries

Back to top